FEATURES OF THE COURSE OF PSEUDOMEMBRANOUS COLITIS IN PATIENTS INFECTED WITH SARS-COV-2
- Authors: Eremina E.Y.1, Gerasimenko I.V.1, Lityushkina M.I.1, Strokova O.A.1
-
Affiliations:
- N.P. Ogarev National Research Mordovia State University
- Issue: Vol 8, No 4 (2022)
- Pages: 71-76
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/289006
- DOI: https://doi.org/10.18565/therapy.2022.471-76
- ID: 289006
Cite item
Abstract
Full Text
About the authors
Elena Yu. Eremina
N.P. Ogarev National Research Mordovia State University
Email: eeu61@mail.ru
Dr med. habil., professor, head of the Department of propaedeutics of internal diseases 430005, Saransk, 68 Bol'shevistskaya Str
Irina V. Gerasimenko
N.P. Ogarev National Research Mordovia State University
Email: gerasimenkoi@list.ru
PhD in Medicine, associate professor of the Department of propaedeutics of internal diseases 430005, Saransk, 68 Bol'shevistskaya Str
Marina I. Lityushkina
N.P. Ogarev National Research Mordovia State University
Email: litjushkina@rambler.ru
PhD in Medicine, associate professor of the Department of propaedeutics of internal diseases 430005, Saransk, 68 Bol'shevistskaya Str
Olga A. Strokova
N.P. Ogarev National Research Mordovia State University
Email: strokovaoa@rambler.ru
PhD in Medicine, associate professor of the Department of propaedeutics of internal diseases 430005, Saransk, 68 Bol'shevistskaya Str
References
- Guan W., Ni Z., Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-20. https://dx.doi.org/.1056/NEJMoa2002032.
- Jin X., Lian J.-S., Hu J.-H. et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020; 69(6): 1002-9. https://dx.doi.org/10.1136/gutjnl-2020-320926.
- Pan L., Mu M., Yang P. et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020; 115(5): 766-73. https://dx.doi.org/10.14309/ajg.0000000000000620.
- Zhou P., Yang X. L., Wang X. G. et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. 2020. https://dx.doi.org/10.1101/2020.01.22.914952.
- Hung I.F., Cheng V.C., Wu A.K. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. 2004; 10(9): 1550-57. https://dx.doi.org/10.3201/eid1009.040058.
- Trottein F., Sokol H. Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection. Cell Rep. 2020; 32(3): 107915. https://dx.doi.org/10.1016/j.celrep.2020.107915.
- Matsumoto M., Kibe R., Ooga T. et al. Cerebral low-molecular metabolites influenced by intestinal microbiota: A pilot study. Front Syst Neurosci. 2013; 7: 9. https://dx.doi.org/10.3389/fnsys.2013.00009.
- Cryan J.F., Dinan T.G. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012; 13(10): 701-12. https://dx.doi.org/10.1038/nrn3346.
- Macfarlane S., Dillon J.F. Microbial biofilms in the human gastrointestinal tract. J Appl Microbiol. 2007; 102(5): 1187-96. https://dx.doi.org/10.1111/j.1365-2672.2007.03287.x.
- Шульпекова Ю.О. Антибиотик-ассоциированная диарея. Русский медицинский журнал. 2007; 3: 467. [Shulpekova Yu.O. antibiotic associated diarrhea.Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2007; 3: 467 (In Russ.)].
- Koh A., de Vadder F., Kovatcheva-Datchary P., Backhed F. et al. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell. 2016; 165(6): 1332-45. https://dx.doi.org/10.1016/j.cell.2016.05.041.
- Kow C.S., Hasan S.S. Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: A meta-analysis. J Intern Med. 2021; 289(1): 125-28. https://dx.doi.org/10.1111/joim.13183.
- Luxenburger H., Sturm L., Biever P. et al. Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients withCOVID-19: Coincidence or underestimated risk factor? J Intern Med. 2021; 289(1): 121-24. https://dx.doi.org/10.1111/joim.13121.
- Еремина Е.Ю. Желудочно-кишечные симптомы у инфицированных SARS-CoV-2: акцент на повышенную проницаемость слизистой оболочки. Медицинский алфавит. 2021; 20: 13-20. [Eremina E.Yu. Gastrointestinal symptoms in SARSCoV 2 infected: emphasis on increased mucosal permeability. Meditsinskiy alfavit = Medical Alphabet. 2021; 20: 13-20 (In Russ.)]. https://dx.doi.org/10.33667/2078-5631-2021-20-13-20.
- Viana S.D., Nunes S., Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis. Ageing Res Rev. 2020; 62: 101123. https://dx.doi.org/10.1016/j.arr.2020.101123.
- Jonsson A.L., Backhed F. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol. 2017; 14(2): 79-87. https://dx.doi.org/10.1038/nrcardio.2016.183